DOLBY LABORATORIES INC-CL A (DLB) Stock Balance Sheet
USA - NYSE:DLB - US25659T1079 - Common Stock
65.77 USD
+0.29 (+0.44%)
65.77 USD
0 (0%)
| MRQ (2025-6-27) | 2024 (2024-9-27) | 2023 (2023-9-29) | 2022 (2022-9-30) | 2021 (2021-9-24) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | null | null | null | null | null | |||
| Cash Equivalents | 698.57M | 482.05M | 745.40M | 620.10M | 1.23B | |||
| Cash Due From Banks | null | null | null | null | null | |||
| Investments | null | null | null | null | null | |||
| Net Loans | null | null | null | null | null | |||
| Insurance Receivables | null | null | null | null | null | |||
| Marketable Securities | 763.00K | 0 | 139.10M | 189.20M | 38.80M | |||
| Receivables | 502.00M | 512.94M | 444.40M | 419.70M | 414.90M | |||
| Inventories | 32.41M | 33.73M | 35.60M | 23.50M | 11.00M | |||
| Other Current Assets | 104.38M | 165.70M | 123.30M | 58.40M | 70.40M | |||
| Total Current Assets | 1.34B | 1.19B | 1.49B | 1.31B | 1.76B | |||
| Non-Current Assets | ||||||||
| PPE Net | 511.43M | 518.15M | 521.80M | 560.00M | 601.50M | |||
| Investments And Advances | 78.02M | 89.27M | 97.80M | 102.50M | 62.80M | |||
| Goodwill | 528.82M | 533.21M | 408.40M | 365.10M | 340.70M | |||
| Intangibles | 408.15M | 434.51M | 167.40M | 112.30M | 122.90M | |||
| Other Non-Current Assets | 331.46M | 340.37M | 296.50M | 238.70M | 217.30M | |||
| Total Non-Current Assets | 1.86B | 1.92B | 1.49B | 1.38B | 1.35B | |||
| TOTAL ASSETS | 3.20B | 3.11B | 2.98B | 2.69B | 3.11B | |||
| LIABILITIES | ||||||||
| Total Deposits | null | null | null | null | null | |||
| Current Liabilities | ||||||||
| Short Term Borrowings | null | null | null | null | null | |||
| Short Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Current Portion Of LT Debt. | null | null | null | null | null | |||
| Accrued Expenses | 198.20M | 203.29M | 214.50M | 180.40M | 205.30M | |||
| Accounts Payable | 17.23M | 17.38M | 20.90M | 14.20M | 17.80M | |||
| Other Current Liabilities | 173.35M | 197.16M | 186.80M | 83.00M | 92.70M | |||
| Total Current Liabilities | 388.79M | 417.84M | 422.20M | 277.50M | 315.70M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0 | 0 | 0 | 0 | 0 | |||
| Deferred Taxes/Income | null | null | null | null | null | |||
| Other Non-Current Liabilities | 192.97M | 205.20M | 185.40M | 161.00M | 185.70M | |||
| Total Non-Current Liabilities | 202.48M | 214.93M | 202.50M | 165.90M | 192.00M | |||
| TOTAL LIABILITIES | 591.27M | 632.77M | 624.70M | 443.40M | 507.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 2.62B | 2.50B | 2.39B | 2.30B | 2.61B | |||
| Additional Paid In Capital | null | null | null | null | null | |||
| Minority Interest | 9.52M | 9.73M | 17.10M | 4.80M | 6.30M | |||
| Common Shares | 94.00K | 94.00K | 100.00K | 100.00K | 100.00K | |||
| Treasury Stock | null | null | null | null | null | |||
| Other Shareholders' Equity | -13.36M | -19.10M | -34.10M | -45.70M | -10.30M | |||
| Shares Outstanding | 95.78M | 95.39M | 95.80M | 95.90M | 101.10M | |||
| Tangible Book Value per Share | 17.4119 | 15.8233 | 18.5731 | 18.4442 | 21.1118 | |||
| Total Shareholders' Equity | 2.60B | 2.48B | 2.36B | 2.25B | 2.60B | |||
| TOTAL LIABILITIES AND EQUITY | 3.20B | 3.11B | 2.98B | 2.69B | 3.11B | |||
| Statistics | ||||||||
| Current Ratio | 3.44 | 2.86 | 3.52 | 4.72 | 5.58 | |||
| Return On Assets (ROA) | 8.27% | 8.42% | 6.74% | 6.85% | 9.99% | |||
| Return On Equity (ROE) | 10.15% | 10.57% | 8.52% | 8.20% | 11.94% | |||
| Return On Invested Capital (ROIC) | 8.51% | 8.12% | 8.49% | 7.44% | 10.09% | |||
| Return On Invested Capital Ex Cash (ROICexc) | 11.34% | 9.90% | 12.98% | 11.20% | 18.45% | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | 20.41% | 17.60% | 19.79% | 15.95% | 26.51% | |||
All data in USD , ROIC based on taxRate of 0.17